k141_253436_1	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	37.2	607	574	703	1.95e-115	357
k141_391988_2	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	34.5	441	431	444	1.98e-65	215
k141_380755_2	SARG|YP_997055	36.5	266	270	274	2.65e-40	139
k141_380755_2	SARG|YP_001563294	35.3	266	270	275	1.50e-39	137
k141_380755_2	SARG|YP_981592	35.2	270	270	277	1.57e-39	137
k141_380755_2	SARG|YP_550152	34.2	266	270	277	4.36e-39	136
k141_380755_2	SARG|ZP_03541894	34.2	269	270	274	1.58e-38	135
k141_380755_2	SARG|YP_523088	36.5	271	270	277	6.62e-38	133
k141_380755_2	SARG|YP_002552549	34.3	268	270	274	3.37e-37	131
k141_380755_2	SARG|YP_985461	34.0	268	270	274	4.73e-37	131
k141_380755_2	SARG|YP_970399	36.4	269	270	274	4.73e-37	131
k141_380755_2	SARG|ZP_03552050	33.7	267	270	274	5.08e-36	128
k141_369429_1	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	30.3	178	260	346	4.83e-18	81.3
k141_242727_8	SARG|gi|511019447|ref|WP_016273783.1|	40.6	286	285	296	1.42e-60	193
k141_242727_8	SARG|P30898	40.2	286	285	296	3.99e-60	192
k141_242727_8	SARG|gb|CAG27800.1|ARO:3003203|TLA-2	35.9	287	285	304	3.41e-54	177
k141_242727_8	SARG|gb|WP_063864748.1|ARO:3006998|SPU-1	38.1	257	285	293	1.56e-52	172
k141_242727_8	SARG|gb|WP_063859920.1|ARO:3006871|CSP-1	38.1	257	285	305	2.16e-52	172
k141_242727_8	NCBI|WP_061710074.1|1|1|blaRAA-1|blaRAA|hydrolase|2|CEPHALOSPORIN|beta-lactam|extended-spectrum_beta-lactamase_RAA-1|AMR|beta-lactam	38.1	257	285	290	2.87e-52	171
k141_242727_8	SARG|gb|BAL40892.1|ARO:3004768|CIA-1	36.0	258	285	292	2.63e-50	166
k141_242727_8	SARG|gb|BAL40893.1|ARO:3004769|CIA-2	36.0	258	285	292	1.46e-49	164
k141_242727_8	SARG|gb|BAL40895.1|ARO:3004771|CIA-4	36.0	258	285	292	1.46e-49	164
k141_242727_8	SARG|gb|AAL55262.1|ARO:3004766|CGA-1	37.5	259	285	292	1.46e-49	164
k141_542631_1	SARG|AJ514254.gene.p01	35.4	181	600	640	1.37e-26	113
k141_543356_1	CARD|gb|BAB38260.1|ARO:3000830|cpxA	32.2	289	454	457	6.48e-36	137
k141_543356_1	SARG|gb|AAG05187.1|ARO:3005067|ParS	31.3	259	454	428	5.25e-31	122
k141_543356_1	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	29.5	200	454	382	4.51e-16	78.6
k141_543356_1	NCBI|WP_063856731.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	29.5	200	454	382	4.51e-16	78.6
k141_543356_1	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	24.7	231	454	357	6.75e-16	77.8
k141_543356_1	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	24.7	231	454	357	6.75e-16	77.8
k141_543356_1	NCBI|WP_063856741.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	28.1	199	454	386	2.66e-15	76.3
k141_543356_1	megares|MEG_7488|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	28.1	199	454	386	2.66e-15	76.3
k141_543356_1	megares|MEG_7487|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	27.8	198	454	386	3.55e-15	75.9
k141_543356_1	NCBI|WP_063856740.1|1|1|vanS-Pt2|vanS-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt2|AMR|glycopeptide	27.8	198	454	386	3.55e-15	75.9
k141_543356_2	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.4	236	230	252	2.97e-45	150
k141_543356_2	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	36.7	221	230	225	3.47e-40	136
k141_543356_2	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	37.0	227	230	228	3.29e-38	131
k141_543356_2	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	36.3	226	230	231	8.59e-36	125
k141_543356_2	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	35.7	227	230	232	4.51e-32	115
k141_543356_2	CARD|gb|AAD51348.1|ARO:3003066|smeR	33.6	220	230	229	1.64e-31	114
k141_543356_2	CARD|gb|ADM92605.1|ARO:3000553|adeR	34.4	227	230	247	4.95e-31	113
k141_543356_2	CARD|gb|AAG06465.1|ARO:3005063|cprR	30.6	222	230	223	8.44e-30	109
k141_543356_2	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	29.6	230	230	233	5.78e-23	92.0
k141_543356_2	SARG|ZP_02848503	30.4	227	230	221	9.19e-22	88.6
k141_417098_2	SARG|gi|835330218|ref|WP_047457825.1|	42.9	219	249	648	2.33e-55	186
k141_417098_2	SARG|YP_001453760	42.9	219	249	648	2.33e-55	186
k141_417098_2	SARG|gi|502669352|ref|WP_012905216.1|	42.5	219	249	648	6.29e-55	185
k141_417098_2	SARG|gi|754927849|ref|WP_042284850.1|	42.9	219	249	648	6.29e-55	185
k141_417098_2	SARG|gi|968563772|ref|WP_058587854.1|	42.5	219	249	648	2.35e-54	184
k141_417098_2	SARG|gi|757782629|ref|WP_043001213.1|	42.5	219	249	648	3.27e-54	183
k141_417098_2	SARG|gi|992390012|ref|WP_061077002.1|	42.5	219	249	648	3.27e-54	183
k141_417098_2	SARG|gi|763407609|ref|WP_044264203.1|	42.5	219	249	648	3.27e-54	183
k141_417098_2	SARG|gi|749017716|ref|WP_040076354.1|	42.5	219	249	646	1.66e-53	181
k141_417098_2	SARG|gi|817104523|ref|WP_046477871.1|	42.5	219	249	648	1.70e-53	181
k141_543423_4	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	40.8	605	814	703	5.65e-132	408
k141_233106_5	SARG|gb|CAE00499.1|ARO:3003835|cdeA	33.5	442	444	441	6.88e-82	258
k141_267816_1	SARG|gi|926351744|ref|WP_053683383.1|	39.5	291	567	648	2.14e-62	216
k141_267816_1	SARG|gi|496018010|ref|WP_008742581.1|	39.3	290	567	623	5.03e-61	211
k141_267816_1	SARG|gi|860594225|ref|WP_048475168.1|	39.3	290	567	620	6.61e-61	211
k141_267816_1	SARG|gi|921231571|ref|WP_053176464.1|	39.5	294	567	620	6.61e-61	211
k141_267816_1	SARG|gi|917172177|ref|WP_051778889.1|	39.5	294	567	620	9.16e-61	211
k141_267816_1	SARG|gi|919568551|ref|WP_052871170.1|	39.5	294	567	620	9.16e-61	211
k141_267816_1	SARG|gi|917229923|ref|WP_051836635.1|	39.2	291	567	620	6.50e-60	208
k141_267816_1	SARG|gi|917166849|ref|WP_051773561.1|	38.8	291	567	620	6.50e-60	208
k141_267816_1	SARG|gi|917155568|ref|WP_051762280.1|	38.8	291	567	620	9.00e-60	208
k141_267816_1	SARG|gi|917203192|ref|WP_051809904.1|	38.8	291	567	620	1.73e-59	207
k141_267816_2	SARG|gi|664352659|ref|WP_030880307.1|	42.0	50	78	601	3.66e-08	47.4
k141_267816_2	SARG|gi|662754041|ref|WP_030125200.1|	42.0	50	78	601	3.66e-08	47.4
k141_267816_2	SARG|gi|664100597|ref|WP_030638327.1|	42.0	50	78	601	3.66e-08	47.4
k141_267816_2	SARG|gi|505389066|ref|WP_015576168.1|	42.0	50	78	601	3.66e-08	47.4
k141_267816_2	SARG|gi|503923650|ref|WP_014157644.1|	42.0	50	78	601	3.66e-08	47.4
k141_267816_2	SARG|gi|917203192|ref|WP_051809904.1|	46.9	49	78	620	3.67e-08	47.4
k141_267816_2	SARG|gi|926356413|ref|WP_053687351.1|	46.9	49	78	620	3.67e-08	47.4
k141_267816_2	SARG|gi|926345639|ref|WP_053677539.1|	46.9	49	78	620	3.67e-08	47.4
k141_267816_2	SARG|gi|799286378|ref|WP_045936958.1|	46.9	49	78	620	3.67e-08	47.4
k141_267816_2	SARG|gi|917127754|ref|WP_051734466.1|	46.9	49	78	620	3.67e-08	47.4
k141_359639_1	SARG|gi|860594225|ref|WP_048475168.1|	44.6	56	60	620	3.34e-08	46.6
k141_359639_1	SARG|gi|926286457|ref|WP_053623344.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|663342223|ref|WP_030341347.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|662175949|ref|WP_030118884.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|664538723|ref|WP_031054357.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|759527374|ref|WP_043247487.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|664194237|ref|WP_030727956.1|	48.1	52	60	605	8.56e-08	45.4
k141_359639_1	SARG|gi|496018010|ref|WP_008742581.1|	53.8	39	60	623	8.56e-08	45.4
k141_359639_1	SARG|gi|917172177|ref|WP_051778889.1|	44.6	56	60	620	1.17e-07	45.1
k141_359639_1	SARG|gi|919568551|ref|WP_052871170.1|	44.6	56	60	620	1.17e-07	45.1
k141_359639_5	SARG|gi|948137056|ref|WP_056795395.1|	35.7	210	330	602	2.74e-38	142
k141_359639_5	SARG|gi|926376632|ref|WP_053705806.1|	35.9	209	330	620	3.14e-38	142
k141_359639_5	SARG|gi|926356413|ref|WP_053687351.1|	35.9	209	330	620	5.91e-38	141
k141_359639_5	SARG|gi|926345639|ref|WP_053677539.1|	35.9	209	330	620	5.91e-38	141
k141_359639_5	SARG|gi|772774655|ref|WP_045322518.1|	34.4	215	330	620	5.91e-38	141
k141_359639_5	SARG|gi|799286378|ref|WP_045936958.1|	35.4	209	330	620	8.11e-38	141
k141_359639_5	SARG|gi|917127754|ref|WP_051734466.1|	35.4	209	330	620	8.11e-38	141
k141_359639_5	SARG|gi|926294973|ref|WP_053631154.1|	35.4	209	330	620	8.11e-38	141
k141_359639_5	SARG|gi|926351744|ref|WP_053683383.1|	34.9	209	330	648	9.71e-38	141
k141_359639_5	SARG|gi|739906046|ref|WP_037756452.1|	34.4	209	330	620	1.53e-37	140
k141_348541_2	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	32.4	222	247	307	2.13e-28	108
k141_348541_2	SARG|gi|738121094|ref|WP_036079133.1|	23.1	199	247	493	4.32e-11	61.2
k141_348541_2	SARG|gi|950193886|ref|WP_057240777.1|	23.2	185	247	492	2.56e-10	58.9
k141_348541_2	SARG|gi|924355535|ref|WP_053488586.1|	22.2	185	247	492	3.45e-10	58.5
k141_348541_2	SARG|gi|1008199138|ref|WP_061860513.1|	22.2	185	247	492	3.45e-10	58.5
k141_348541_2	SARG|gi|738205817|ref|WP_036161732.1|	23.6	178	247	492	8.39e-10	57.4
k141_348541_2	SARG|gi|651595894|ref|WP_026590859.1|	23.6	182	247	492	8.39e-10	57.4
k141_348541_2	SARG|gi|495453058|ref|WP_008177752.1|	23.6	178	247	492	1.13e-09	57.0
k141_348541_2	SARG|gi|517204321|ref|WP_018393139.1|	23.1	199	247	492	1.13e-09	57.0
k141_348541_2	SARG|gi|496784101|ref|WP_009371362.1|	24.1	191	247	493	1.52e-09	56.6
k141_417772_7	NCBI|AAN29871.1|1|1|bepC|bepC||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_subunit_BepC|AMR|efflux	41.9	62	62	456	2.92e-06	41.2
k141_395502_3	SARG|gi|446026113|ref|WP_000103968.1|	30.9	233	262	306	1.07e-30	115
k141_395502_3	SARG|gi|507044560|ref|WP_016115614.1|	30.9	233	262	306	1.49e-30	114
k141_395502_3	SARG|gi|542061059|gb|ERI11611.1|	30.4	240	262	316	4.90e-30	113
k141_395502_3	SARG|gi|445996719|ref|WP_000074574.1|	31.0	229	262	309	3.17e-29	111
k141_395502_3	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.3	221	262	343	7.92e-29	110
k141_395502_3	SARG|gi|500448961|gb|EOP61695.1|	30.0	233	262	306	8.14e-29	110
k141_395502_3	SARG|gi|445996710|ref|WP_000074565.1|	31.3	230	262	309	8.59e-29	110
k141_395502_3	SARG|gi|500465078|gb|EOP76697.1|	30.0	233	262	306	1.13e-28	109
k141_395502_3	SARG|gi|895736250|emb|COF64653.1|	30.9	230	262	309	3.24e-28	108
k141_395502_3	SARG|gi|446110087|ref|WP_000187942.1|	30.9	230	262	309	3.24e-28	108
k141_395502_6	NCBI|WP_002349981.1|1|1|cfr(B)|cfr(B)|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/LINEZOLID/RETAPAMULIN/STREPTOGRAMIN_B/VIRGINIAMYCIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr(B)|AMR|multidrug	39.6	255	250	349	1.71e-43	149
k141_395502_6	SARG|gb|CDF47262.1|ARO:3004649|cfr(B)	39.6	255	250	349	1.71e-43	149
k141_395502_6	NCBI|WP_032491462.1|1|1|cfr|cfr|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/FLORFENICOL/LINEZOLID/STREPTOGRAMIN_B/TIAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr|AMR|multidrug	40.0	255	250	349	4.75e-43	148
k141_395502_6	SARG|gb|AIX48090.1|ARO:3004599|clcD	39.2	255	250	349	6.67e-43	147
k141_395502_6	SARG|CP001581.1.gene3143.p01	38.7	253	250	344	1.18e-42	147
k141_395502_6	SARG|AJ249217.gene.p01	40.0	255	250	349	1.31e-42	147
k141_395502_6	SARG|gb|AGZ55247.1|ARO:3002814|clbA	40.0	255	250	349	1.41e-41	144
k141_395502_6	SARG|gb|CAL84423.1|ARO:3004146|cfrC	37.9	253	250	344	2.49e-41	143
k141_395502_6	SARG|gb|ACX65640.1|ARO:3003907|cipA	37.8	249	250	346	1.51e-39	139
k141_395502_6	SARG|gb|BAH45481.1|ARO:3002815|clbB	37.3	249	250	343	2.97e-38	135
k141_395591_2	SARG|CAB61227	26.8	340	305	343	1.51e-26	105
k141_522292_1	SARG|gi|491186452|ref|WP_005044810.1|	34.1	211	198	446	7.96e-26	102
k141_522292_1	SARG|gi|515957791|ref|WP_017388374.1|	34.1	211	198	446	1.10e-25	101
k141_522292_1	SARG|gi|496866281|ref|WP_009390736.1|	34.1	211	198	445	2.07e-25	100
k141_522292_1	SARG|gi|490932812|ref|WP_004794665.1|	33.6	211	198	446	2.08e-25	100
k141_522292_1	SARG|gi|691114891|ref|WP_032035334.1|	33.6	211	198	446	2.08e-25	100
k141_522292_1	SARG|gi|507068488|ref|WP_016139267.1|	33.6	211	198	446	2.08e-25	100
k141_522292_1	SARG|gi|502963983|ref|WP_013198959.1|	33.6	211	198	446	2.08e-25	100
k141_522292_1	SARG|gi|691112668|ref|WP_032033542.1|	34.6	211	198	445	2.84e-25	100
k141_522292_1	SARG|gi|447046965|ref|WP_001124221.1|	34.6	211	198	445	2.84e-25	100
k141_522292_1	SARG|gi|770625864|ref|WP_045126264.1|	33.6	211	198	446	2.86e-25	100
k141_522292_2	SARG|gi|446657977|ref|WP_000735323.1|	25.9	379	448	438	1.76e-18	86.3
k141_522292_2	SARG|gi|446657997|ref|WP_000735343.1|	25.5	377	448	436	1.80e-17	83.2
k141_522292_2	SARG|gi|498003897|ref|WP_010318053.1|	25.0	400	448	438	3.25e-17	82.4
k141_522292_2	SARG|gi|950975844|ref|WP_057554965.1|	25.3	376	448	436	4.30e-17	82.0
k141_522292_2	SARG|gi|446657993|ref|WP_000735339.1|	25.3	376	448	436	4.30e-17	82.0
k141_522292_2	SARG|gi|446657995|ref|WP_000735341.1|	25.3	376	448	436	5.75e-17	81.6
k141_522292_2	SARG|gi|446657994|ref|WP_000735340.1|	25.3	379	448	438	7.75e-17	81.3
k141_522292_2	SARG|gi|446657996|ref|WP_000735342.1|	24.9	378	448	438	7.75e-17	81.3
k141_522292_2	SARG|gi|694144291|ref|WP_032481917.1|	25.6	379	448	438	1.04e-16	80.9
k141_522292_2	SARG|gi|446657992|ref|WP_000735338.1|	25.3	379	448	438	1.38e-16	80.5
k141_269039_9	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.0	230	244	232	3.80e-48	157
k141_269039_9	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.0	230	244	232	3.80e-48	157
k141_269039_9	CARD|gb|AAC73788.1|ARO:3003841|kdpE	39.4	208	244	225	6.19e-45	149
k141_269039_9	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	39.5	205	244	225	8.75e-45	149
k141_269039_9	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.4	229	244	231	5.80e-44	147
k141_269039_9	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	39.7	229	244	232	5.96e-44	147
k141_269039_9	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	39.3	229	244	231	1.16e-43	146
k141_269039_9	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.3	229	244	231	1.16e-43	146
k141_269039_9	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.4	229	244	231	6.46e-43	144
k141_269039_9	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	39.7	234	244	235	7.21e-43	144
k141_269039_12	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	33.3	177	301	346	2.90e-16	77.0
k141_132079_1	SARG|gb|AAC75089.1|ARO:3003577|ugd	31.3	355	367	388	3.99e-48	166
k141_327358_1	SARG|gi|926294973|ref|WP_053631154.1|	43.2	257	566	620	6.06e-58	203
k141_327358_1	SARG|gi|496018010|ref|WP_008742581.1|	42.6	256	566	623	6.38e-58	203
k141_327358_1	SARG|gi|926356413|ref|WP_053687351.1|	43.2	257	566	620	8.39e-58	202
k141_327358_1	SARG|gi|926376632|ref|WP_053705806.1|	42.8	257	566	620	1.61e-57	202
k141_327358_1	SARG|gi|917229923|ref|WP_051836635.1|	42.8	257	566	620	3.07e-57	201
k141_327358_1	SARG|gi|917166849|ref|WP_051773561.1|	42.4	257	566	620	3.07e-57	201
k141_327358_1	SARG|gi|799286378|ref|WP_045936958.1|	42.8	257	566	620	3.07e-57	201
k141_327358_1	SARG|gi|917127754|ref|WP_051734466.1|	42.8	257	566	620	3.07e-57	201
k141_327358_1	SARG|gi|1045390184|ref|WP_065479071.1|	41.2	262	566	605	3.31e-57	201
k141_327358_1	SARG|gi|917155568|ref|WP_051762280.1|	42.4	257	566	620	4.25e-57	201
k141_408365_2	SARG|gb|ADZ12699.1|ARO:3005091|RanA	34.6	240	251	258	1.41e-50	165
k141_408365_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.2	222	251	255	2.91e-30	112
k141_408365_2	SARG|gb|APB03219.1|ARO:3003986|TaeA	23.3	232	251	648	3.53e-12	64.7
k141_408365_2	SARG|gb|AVI44920.1|ARO:3004470|poxtA	23.8	214	251	542	2.11e-10	59.3
k141_408365_2	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	23.8	214	251	544	2.11e-10	59.3
k141_408365_2	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	23.5	217	251	504	7.43e-08	51.6
k141_408365_2	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	22.9	240	251	505	9.97e-08	51.2
k141_132817_23	SARG|gb|AAC75314.1|ARO:3003578|pmrF	30.9	94	292	322	6.59e-06	45.8
k141_281582_1	SARG|NP_348076	35.5	304	315	652	6.87e-48	169
k141_281582_1	SARG|YP_002850805	36.2	271	315	652	2.30e-45	162
k141_281582_1	SARG|ZP_02952732	36.2	271	315	652	3.17e-45	161
k141_281582_1	SARG|L20800.gene.p01	36.2	271	315	652	3.17e-45	161
k141_281582_1	SARG|ZP_02632674	36.2	271	315	660	3.41e-45	161
k141_281582_1	megares|MEG_7167|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	265	315	639	6.24e-42	152
k141_281582_1	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	265	315	629	7.90e-42	152
k141_281582_1	ResF|tet(O/W)_3_AM889120_1	34.7	265	315	639	8.59e-42	152
k141_281582_1	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	265	315	629	1.09e-41	151
k141_281582_1	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	265	315	629	1.09e-41	151
k141_63642_1	SARG|gb|BAE78116.1|ARO:3003576|eptA	49.2	252	254	547	2.85e-86	265
k141_63642_1	CARD|gb|BCG06510.1|ARO:3007266|MCR-3.20	44.0	248	254	447	1.02e-84	258
k141_63642_1	SARG|gb|AUN87920.1|ARO:3004500|MCR-3.11	44.4	248	254	541	1.08e-84	261
k141_63642_1	SARG|WP_065804663.1	44.4	248	254	541	1.52e-84	261
k141_63642_1	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	44.4	248	254	541	1.52e-84	261
k141_63642_1	NCBI|WP_042649073.1|1|1|mcr-3_set|mcr-3_set||2|COLISTIN|COLISTIN|MCR-3-related_phosphoethanolamine--lipid_A_transferase|AMR|peptide	44.4	248	254	541	2.14e-84	260
k141_63642_1	NCBI|WP_150823496.1|1|1|mcr-3.28|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.28|AMR|peptide	44.4	248	254	541	2.14e-84	260
k141_63642_1	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	44.4	248	254	541	2.14e-84	260
k141_63642_1	SARG|ASU04896.1	44.4	248	254	541	4.26e-84	259
k141_63642_1	SARG|WP_065801616.1	44.0	248	254	541	1.19e-83	258
k141_420909_6	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	28.4	370	362	712	8.30e-26	107
k141_420909_6	SARG|AAY67970	29.5	370	362	698	1.30e-23	101
k141_420909_6	SARG|gi|498467693|ref|WP_010773049.1|	28.1	342	362	700	1.75e-23	100
k141_420909_6	SARG|AF162694.1.gene4.p01	30.1	336	362	698	7.70e-23	99.0
k141_420909_6	SARG|gi|657686198|ref|WP_029487032.1|	30.1	336	362	698	7.70e-23	99.0
k141_420909_10	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	33.7	421	438	481	1.56e-58	198
k141_420909_10	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	33.6	423	438	451	2.19e-58	197
k141_420909_10	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	32.5	428	438	451	8.79e-57	192
k141_501762_2	SARG|gi|922960663|ref|WP_053388845.1|	48.2	220	243	648	3.13e-62	204
k141_501762_2	SARG|gi|757799695|ref|WP_043016897.1|	48.2	220	243	648	4.37e-62	204
k141_501762_2	SARG|gi|1045891604|ref|WP_065554100.1|	48.2	220	243	648	4.37e-62	204
k141_501762_2	SARG|gi|507082903|ref|WP_016153652.1|	48.2	220	243	648	4.37e-62	204
k141_501762_2	SARG|gi|740856590|ref|WP_038641842.1|	48.2	220	243	648	4.37e-62	204
k141_501762_2	SARG|gi|507086196|ref|WP_016156937.1|	48.2	220	243	648	4.37e-62	204
k141_501762_2	SARG|gi|491270241|ref|WP_005128370.1|	48.2	220	243	648	6.10e-62	204
k141_501762_2	SARG|gi|696368937|ref|WP_032943949.1|	50.2	209	243	648	6.10e-62	204
k141_501762_2	SARG|gi|835233765|ref|WP_047410073.1|	48.2	220	243	648	6.10e-62	204
k141_501762_2	SARG|gi|754951242|ref|WP_042307417.1|	48.2	220	243	648	6.10e-62	204
k141_501762_3	SARG|gb|AAV85982.1|ARO:3000535|macB	32.3	393	406	644	1.03e-42	157
k141_501762_3	SARG|YP_002044935	31.8	337	406	648	1.23e-35	137
k141_501762_3	SARG|gi|924503108|ref|WP_053510027.1|	32.0	337	406	648	1.68e-35	137
k141_501762_3	SARG|gi|924626178|ref|WP_053530123.1|	31.5	337	406	648	3.10e-35	136
k141_501762_3	SARG|gi|446048045|ref|WP_000125900.1|	31.4	341	406	648	5.74e-35	135
k141_501762_3	SARG|gi|487596081|ref|WP_001728978.1|	31.5	337	406	648	5.74e-35	135
k141_501762_3	SARG|YP_002242988	31.5	337	406	648	5.74e-35	135
k141_501762_3	SARG|gi|555268037|ref|WP_023249477.1|	31.8	337	406	648	7.81e-35	135
k141_501762_3	SARG|gi|959101689|ref|WP_058107049.1|	31.5	337	406	648	7.81e-35	135
k141_501762_3	SARG|gi|959109145|ref|WP_058113944.1|	31.5	337	406	648	7.81e-35	135
k141_455312_4	SARG|gb|AAC74000.1|ARO:3003950|msbA	45.5	242	586	582	6.85e-62	213
k141_455312_4	SARG|gi|860594225|ref|WP_048475168.1|	37.7	268	586	620	6.58e-58	203
k141_455312_4	SARG|gi|926351744|ref|WP_053683383.1|	37.7	268	586	648	1.43e-57	203
k141_455312_4	SARG|gi|648667297|ref|WP_026359044.1|	34.6	315	586	605	3.57e-57	201
k141_455312_4	SARG|gi|663350985|ref|WP_030349761.1|	37.7	268	586	613	7.80e-57	200
k141_455312_4	SARG|gi|1045390184|ref|WP_065479071.1|	36.2	268	586	605	1.30e-56	199
k141_455312_4	SARG|gi|695842130|ref|WP_032755430.1|	36.6	268	586	603	1.74e-56	199
k141_455312_4	SARG|gi|493394434|ref|WP_006350564.1|	35.8	268	586	602	4.52e-56	198
k141_455312_4	SARG|AF170880.4.gene1.p01	34.2	316	586	615	5.61e-56	198
k141_455312_4	SARG|gi|917166849|ref|WP_051773561.1|	36.9	268	586	620	8.40e-56	197
k141_455312_5	SARG|gi|817122037|ref|WP_046494699.1|	42.3	284	590	613	9.74e-69	233
k141_455312_5	SARG|gi|493394434|ref|WP_006350564.1|	43.9	255	590	602	1.08e-68	232
k141_455312_5	SARG|gi|1045390184|ref|WP_065479071.1|	43.3	270	590	605	4.32e-68	231
k141_455312_5	SARG|gi|1033217078|gb|OAR27197.1|	43.0	270	590	601	5.54e-68	230
k141_455312_5	SARG|gi|663350985|ref|WP_030349761.1|	44.3	255	590	613	1.37e-67	229
k141_455312_5	SARG|gi|695842130|ref|WP_032755430.1|	43.3	270	590	603	4.19e-67	228
k141_455312_5	SARG|gi|505420018|ref|WP_015607120.1|	43.3	270	590	603	4.19e-67	228
k141_455312_5	SARG|gi|948137056|ref|WP_056795395.1|	43.0	270	590	602	5.71e-67	228
k141_455312_5	SARG|gi|695865802|ref|WP_032778631.1|	43.0	270	590	605	6.07e-67	228
k141_455312_5	SARG|gi|928900436|ref|WP_053931243.1|	44.7	255	590	600	2.05e-66	226
k141_443218_4	SARG|gi|657888313|ref|WP_029592374.1|	28.2	213	260	648	2.58e-10	59.3
k141_443218_4	SARG|gi|639225329|ref|WP_024561799.1|	27.1	214	260	648	1.51e-09	57.0
k141_443218_4	SARG|gi|639218559|ref|WP_024556062.1|	27.1	214	260	648	1.51e-09	57.0
k141_443218_4	SARG|gi|851928815|ref|WP_048221086.1|	25.4	244	260	648	1.51e-09	57.0
k141_443218_4	SARG|gi|780033092|ref|WP_045444768.1|	25.4	244	260	648	1.51e-09	57.0
k141_443218_4	SARG|gi|639216333|ref|WP_024554080.1|	26.6	207	260	648	2.02e-09	56.6
k141_443218_4	SARG|gi|803568669|ref|WP_046077412.1|	25.9	212	260	648	3.63e-09	55.8
k141_443218_4	SARG|gi|446110352|ref|WP_000188207.1|	25.9	212	260	648	3.63e-09	55.8
k141_443218_4	SARG|YP_002382193	25.9	212	260	648	3.63e-09	55.8
k141_443218_4	SARG|gi|803575554|ref|WP_046081557.1|	25.9	212	260	648	3.63e-09	55.8
k141_465738_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.7	221	229	219	1.25e-50	163
k141_465738_6	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.9	225	229	219	4.99e-38	130
k141_465738_6	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.9	225	229	219	7.04e-38	130
k141_465738_6	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.9	225	229	220	7.23e-38	130
k141_465738_6	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.9	225	229	220	1.44e-37	129
k141_465738_6	CARD|gb|ADM92605.1|ARO:3000553|adeR	34.1	229	229	247	2.05e-37	130
k141_465738_6	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	35.0	223	229	231	7.57e-37	128
k141_465738_6	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	29.7	229	229	233	1.74e-35	124
k141_465738_6	CARD|gb|AAG06465.1|ARO:3005063|cprR	34.2	222	229	223	7.47e-35	122
k141_465738_6	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	33.6	226	229	232	2.62e-34	121
k141_6647_2	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	53.8	104	115	1107	1.84e-36	129
k141_6647_2	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	53.8	104	115	1107	1.84e-36	129
k141_6647_2	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	54.8	93	115	1024	8.04e-33	119
k141_6647_2	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	54.8	93	115	1024	8.04e-33	119
k141_6647_2	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	54.8	93	115	1024	8.04e-33	119
k141_6647_2	SARG|gb|CAA53189|ARO:3000521|mupA	54.8	93	115	1024	8.04e-33	119
k141_6647_2	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	52.6	95	115	1033	3.80e-32	117
k141_6647_2	SARG|gb|AEY83581|ARO:3000510|mupB	52.6	95	115	1033	3.80e-32	117
k141_202127_5	SARG|gi|1004359922|gb|AMP42228.1|	23.3	447	601	639	1.33e-24	107
k141_202127_5	SARG|AAV80410	21.9	456	601	651	2.42e-24	106
k141_202127_5	SARG|ABV82118	21.5	447	601	639	3.11e-24	106
k141_202127_5	SARG|Q52360	24.0	470	601	641	3.13e-24	106
k141_202127_5	SARG|ABV82120	21.5	447	601	639	7.30e-24	105
k141_202127_5	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	22.8	448	601	629	9.43e-24	104
k141_202127_5	SARG|AJ295238.gene.p01	22.3	467	601	639	9.70e-24	104
k141_202127_5	ResF|tet(O/W)_4_AM889121_1	22.8	448	601	639	9.70e-24	104
k141_202127_5	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	22.8	448	601	629	1.25e-23	104
k141_202127_5	ResF|tet(O/W)_5_AM889122_1	22.8	448	601	639	1.29e-23	104
k141_202127_8	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	31.4	331	378	397	3.72e-45	159
k141_317433_7	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	22.9	838	826	1033	1.67e-32	134
k141_317433_7	SARG|gb|AEY83581|ARO:3000510|mupB	22.9	838	826	1033	1.67e-32	134
k141_317433_7	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	23.5	821	826	1024	4.65e-31	130
k141_317433_7	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	23.5	821	826	1024	4.65e-31	130
k141_317433_7	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	23.5	821	826	1024	4.65e-31	130
k141_317433_7	SARG|gb|CAA53189|ARO:3000521|mupA	23.5	821	826	1024	4.65e-31	130
k141_317433_19	SARG|gb|AAC75271.1|ARO:3003952|yojI	25.8	120	116	547	4.40e-09	51.6
k141_317433_19	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.6	98	116	664	1.56e-08	50.1
k141_317433_19	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.0	80	116	579	9.88e-08	47.8
k141_317433_19	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	30.0	80	116	579	9.88e-08	47.8
k141_317433_19	SARG|gb|WP_082039181.1|ARO:3007028|salD	34.7	75	116	544	4.62e-07	45.8
k141_30155_3	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	45.9	701	675	1107	2.22e-202	598
k141_30155_3	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	45.9	701	675	1107	2.22e-202	598
k141_30155_3	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	33.5	692	675	1024	7.87e-125	394
k141_30155_3	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	33.5	692	675	1024	7.87e-125	394
k141_30155_3	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	34.7	639	675	1024	3.31e-122	387
k141_30155_3	SARG|gb|CAA53189|ARO:3000521|mupA	34.7	639	675	1024	3.31e-122	387
k141_30155_3	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	34.1	668	675	1033	6.03e-120	381
k141_30155_3	SARG|gb|AEY83581|ARO:3000510|mupB	34.1	668	675	1033	6.03e-120	381
k141_237417_5	SARG|gi|851935911|ref|WP_048224705.1|	26.7	281	303	660	4.57e-23	98.2
k141_237417_5	SARG|gi|1002399350|ref|WP_061382108.1|	26.7	281	303	660	1.13e-22	97.1
k141_237417_5	SARG|gi|757799830|ref|WP_043017032.1|	26.7	281	303	660	5.07e-22	95.1
k141_237417_5	SARG|gi|489117806|ref|WP_003027650.1|	26.7	281	303	660	1.69e-21	93.6
k141_237417_5	SARG|gi|851912779|ref|WP_048215868.1|	26.3	281	303	660	2.28e-21	93.2
k141_237417_5	SARG|gi|851981245|ref|WP_048240645.1|	26.7	281	303	660	2.28e-21	93.2
k141_237417_5	SARG|gi|851917461|ref|WP_048217311.1|	26.3	281	303	660	3.07e-21	92.8
k141_237417_5	SARG|gi|696375142|ref|WP_032949690.1|	26.3	281	303	660	3.07e-21	92.8
k141_237417_5	SARG|gi|765458296|ref|WP_044714032.1|	26.3	281	303	660	4.15e-21	92.4
k141_237417_5	SARG|YP_002850217	26.5	283	303	660	1.38e-20	90.9
k141_329580_1	SARG|HE999704.1.gene1126.p01	27.1	240	330	337	6.18e-19	85.1
k141_329580_1	SARG|gi|441473784|emb|CCQ23538.1|	27.1	240	330	336	1.14e-18	84.3
k141_329580_1	SARG|gi|313614636|gb|EFR88215.1|	27.1	240	330	453	2.43e-18	84.3
k141_329580_1	SARG|gi|313638554|gb|EFS03703.1|	26.3	240	330	453	8.75e-17	79.7
k141_329580_1	SARG|gi|984518628|emb|CUM21384.1|	26.7	176	330	341	2.41e-12	65.9
k141_53124_3	SARG|ZP_04638974	33.7	409	640	563	1.55e-46	172
k141_53124_3	SARG|YP_001007250	33.7	409	640	563	7.47e-46	170
k141_53124_3	SARG|ZP_04631861	34.2	386	640	543	1.41e-45	169
k141_53124_3	SARG|YP_001401994	34.0	388	640	563	2.61e-45	168
k141_53124_3	SARG|ZP_04630103	34.2	386	640	543	2.65e-45	168
k141_53124_3	SARG|AAS61092	34.0	388	640	563	3.57e-45	168
k141_53124_3	SARG|ZP_04612557	34.5	386	640	543	4.96e-45	167
k141_53124_3	SARG|gi|740410309|ref|WP_038243756.1|	32.5	409	640	563	6.68e-45	167
k141_53124_3	SARG|ZP_04623897	34.2	386	640	543	9.29e-45	166
k141_53124_3	SARG|gi|318604694|emb|CBY26192.1|	33.9	386	640	540	1.21e-44	166
k141_295116_7	SARG|gb|APB03219.1|ARO:3003986|TaeA	32.4	624	602	648	1.50e-93	300
k141_295116_7	SARG|gb|AVI44920.1|ARO:3004470|poxtA	30.0	543	602	542	1.57e-59	206
k141_295116_7	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	30.0	543	602	544	1.63e-59	206
k141_295116_7	SARG|gb|NP_388442.1|ARO:3004476|vmlR	30.8	503	602	547	5.85e-55	194
k141_295116_7	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.5	550	602	655	7.00e-55	196
k141_295116_7	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	550	602	655	3.46e-54	194
k141_295116_7	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	550	602	655	3.46e-54	194
k141_295116_7	megares|MEG_4314|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	550	602	655	3.46e-54	194
k141_295116_7	megares|MEG_4319|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	550	602	655	3.46e-54	194
k141_295116_7	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	550	602	655	3.46e-54	194
k141_295116_9	megares|MEG_4054|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	31.9	307	315	880	1.16e-28	115
k141_295116_9	SARG|gb|Q8FW76|ARO:3003772|Brucella	31.9	307	315	880	1.16e-28	115
k141_433376_3	SARG|gb|AAC75314.1|ARO:3003578|pmrF	32.8	320	325	322	1.05e-43	151
k141_283877_6	SARG|gi|740519593|ref|WP_038347927.1|	32.4	324	391	406	4.51e-44	156
k141_283877_6	SARG|gi|445932788|ref|WP_000010643.1|	32.1	324	391	406	1.22e-43	155
k141_283877_6	NCBI|AAN33535.1|1|1|bepF|bepF|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_BepF|AMR|efflux	33.7	306	391	411	1.37e-42	152
k141_283877_6	SARG|CAG34256	33.8	355	391	394	1.95e-40	146
k141_283877_6	SARG|YP_002706076	33.5	355	391	394	3.77e-40	145
k141_283877_6	SARG|CAC14594	33.5	355	391	394	7.28e-40	145
k141_283877_6	SARG|YP_002029850	33.5	355	391	393	1.92e-39	144
k141_283877_6	SARG|CAG34264	33.5	355	391	394	1.96e-39	144
k141_283877_6	SARG|CAG34249	33.2	355	391	394	3.78e-39	143
k141_283877_6	NCBI|AAU10477.1|1|1|adeD|adeD|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_AdeD|AMR|efflux	32.1	293	391	374	9.59e-37	136
k141_283877_7	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	41.7	1039	1035	1074	8.47e-250	733
k141_283877_7	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	40.4	1040	1035	1051	5.01e-239	704
k141_283877_7	SARG|gi|654933144|ref|WP_028383500.1|	39.8	1055	1035	1063	1.08e-231	686
k141_283877_7	SARG|gi|491017944|ref|WP_004879650.1|	40.0	1047	1035	1063	6.04e-231	684
k141_283877_7	SARG|CP000675.2.gene2723.p01	39.6	1053	1035	1050	1.15e-230	682
k141_283877_7	SARG|gi|496667122|ref|WP_009309612.1|	41.4	1036	1035	1036	1.18e-229	679
k141_283877_7	SARG|gi|694076105|ref|WP_032421853.1|	41.3	1036	1035	1036	1.18e-229	679
k141_283877_7	SARG|CP000647.1.gene3710.p01	41.3	1033	1035	1036	2.35e-229	679
k141_283877_7	SARG|gi|966511896|ref|WP_058528450.1|	38.5	1049	1035	1061	2.50e-229	679
k141_283877_7	SARG|gi|940417834|ref|WP_055007142.1|	39.8	1044	1035	1063	2.65e-229	679
k141_111220_4	NCBI|WP_071846282.1|1|1|dfrA12|dfrA12|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA12|AMR|diaminopyrimidine	37.4	99	194	165	3.40e-11	58.2
k141_111220_4	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	27.9	111	194	163	4.56e-11	57.8
k141_111220_4	SARG|AAT45231	37.4	99	194	165	4.72e-11	57.8
k141_111220_4	SARG|gb|WP_149100971.1|ARO:3005351|DfrA39	31.1	119	194	165	4.72e-11	57.8
k141_111220_4	SARG|gi|647323550|ref|WP_025760450.1|	34.7	95	194	165	4.72e-11	57.8
k141_111220_4	NCBI|WP_071846383.1|1|1|dfrA12|dfrA12|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA12|AMR|diaminopyrimidine	37.4	99	194	165	6.54e-11	57.4
k141_111220_4	SARG|gi|692958302|ref|WP_032151894.1|	37.4	99	194	165	6.54e-11	57.4
k141_111220_4	SARG|ABJ15828	37.4	99	194	165	6.54e-11	57.4
k141_111220_4	SARG|AAW21254	37.4	99	194	165	6.54e-11	57.4
k141_111220_4	NCBI|WP_070342368.1|1|1|dfrA12|dfrA12|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA12|AMR|diaminopyrimidine	37.4	99	194	165	6.54e-11	57.4
k141_135347_2	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	32.8	189	397	639	1.93e-16	80.1
k141_214427_3	SARG|YP_002850805	27.6	471	530	652	8.02e-41	155
k141_214427_3	SARG|L20800.gene.p01	26.8	470	530	652	1.09e-40	154
k141_214427_3	SARG|NP_348076	26.6	455	530	652	2.75e-40	153
k141_214427_3	SARG|ZP_02952732	26.6	470	530	652	6.92e-40	152
k141_214427_3	SARG|ZP_02632674	26.6	470	530	660	7.36e-40	152
k141_214427_3	SARG|Q02652	28.1	459	530	639	9.62e-37	143
k141_214427_3	SARG|CAA37477	28.6	468	530	663	2.05e-36	142
k141_99692_1	NCBI|WP_063865552.1|1|1|oqxB4|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB4|AMR|multidrug	45.3	404	404	1050	6.41e-111	348
k141_99692_1	NCBI|WP_023323140.1|1|1|oqxB15|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB15|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_021312368.1|1|1|oqxB20|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB20|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_040224644.1|1|1|oqxB27|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB27|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_004149399.1|1|1|oqxB19|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB19|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_004174783.1|1|1|oqxB5|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB5|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_063865404.1|1|1|oqxB10|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB10|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_063865408.1|1|1|oqxB11|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB11|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_063865413.1|1|1|oqxB12|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB12|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_1	NCBI|WP_063865418.1|1|1|oqxB13|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB13|AMR|multidrug	45.3	404	404	1050	8.95e-111	347
k141_99692_2	SARG|gi|691049634|ref|WP_031996802.1|	25.8	345	377	405	1.47e-31	122
k141_99692_2	SARG|gi|691041848|ref|WP_031992413.1|	25.8	345	377	406	1.49e-31	122
k141_99692_2	SARG|gi|690976923|ref|WP_031951175.1|	25.8	345	377	406	1.49e-31	122
k141_99692_2	SARG|gi|691085756|ref|WP_032019894.1|	25.8	345	377	406	2.06e-31	122
k141_99692_2	SARG|gi|445932791|ref|WP_000010646.1|	25.5	345	377	405	2.80e-31	121
k141_99692_2	SARG|gi|691067173|ref|WP_032009467.1|	25.5	345	377	406	2.84e-31	121
k141_99692_2	SARG|gi|691043443|ref|WP_031993178.1|	25.5	345	377	406	2.84e-31	121
k141_99692_2	SARG|gi|445932785|ref|WP_000010640.1|	25.5	345	377	406	2.84e-31	121
k141_99692_2	SARG|gi|445932789|ref|WP_000010644.1|	25.5	345	377	405	3.86e-31	121
k141_99692_2	SARG|NC_010400.5984910.p01	25.5	345	377	405	3.86e-31	121
k141_538019_24	SARG|gb|ADZ12700.1|ARO:3005090|RanB	35.6	250	264	253	5.13e-40	138
k141_538019_25	SARG|gb|ADZ12699.1|ARO:3005091|RanA	38.3	243	257	258	2.69e-49	162
k141_538019_25	SARG|gi|671541568|ref|WP_031525212.1|	30.2	222	257	648	1.65e-25	103
k141_538019_25	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	27.4	208	257	293	3.88e-19	83.6
k141_538019_25	SARG|gi|695887424|ref|WP_032788534.1|	28.2	234	257	605	2.14e-18	83.2
k141_538019_25	SARG|gi|764446018|ref|WP_044369325.1|	27.8	234	257	605	2.14e-18	83.2
k141_538019_25	SARG|gi|664180077|ref|WP_030714054.1|	28.2	234	257	605	2.14e-18	83.2
k141_538019_25	SARG|gi|1045390184|ref|WP_065479071.1|	27.5	251	257	605	2.90e-18	82.8
k141_538019_25	SARG|gi|497748188|ref|WP_010062372.1|	29.3	239	257	605	5.30e-18	82.0
k141_538019_25	SARG|gi|662129758|ref|WP_030081404.1|	27.1	251	257	605	7.16e-18	81.6
k141_538019_25	SARG|gi|695865802|ref|WP_032778631.1|	27.1	251	257	605	9.69e-18	81.3
k141_182083_1	SARG|gi|446657948|ref|WP_000735294.1|	23.2	314	365	493	4.56e-24	102
k141_182083_1	SARG|gi|545470455|ref|WP_021706937.1|	25.1	307	365	445	1.14e-23	100
k141_182083_1	SARG|gi|757717795|ref|WP_042946052.1|	23.4	334	365	482	1.97e-23	100
k141_182083_1	SARG|gi|695769902|ref|WP_032692881.1|	22.9	332	365	482	2.66e-23	99.8
k141_182083_1	SARG|gi|1033067325|ref|WP_064377960.1|	22.9	332	365	482	2.66e-23	99.8
k141_182083_1	SARG|gi|695806179|ref|WP_032720252.1|	22.9	332	365	482	2.66e-23	99.8
k141_182083_1	SARG|gi|503992881|ref|WP_014226875.1|	22.9	332	365	482	2.66e-23	99.8
k141_182083_1	SARG|gi|490992519|ref|WP_004854252.1|	22.9	332	365	482	2.66e-23	99.8
k141_182083_1	SARG|gi|493932882|ref|WP_006877374.1|	27.2	334	365	436	2.69e-23	99.4
k141_182083_1	SARG|gi|922032953|ref|WP_053310753.1|	25.7	315	365	437	2.71e-23	99.4
k141_76562_2	NCBI|WP_111273846.1|1|1|mcr-3.17|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.17|AMR|peptide	34.0	212	221	540	1.89e-23	96.7
k141_76562_2	NCBI|WP_111273843.1|1|1|mcr-3.14|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.14|AMR|peptide	32.7	211	221	540	8.86e-23	94.7
k141_76562_2	NCBI|WP_188331896.1|1|1|mcr-3.37|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.37|AMR|peptide	33.5	215	221	540	1.21e-22	94.4
k141_76562_2	NCBI|WP_150823496.1|1|1|mcr-3.28|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.28|AMR|peptide	33.5	215	221	541	1.65e-22	94.0
k141_76562_2	SARG|WP_087879616.1	33.5	215	221	541	1.65e-22	94.0
k141_76562_2	SARG|ASU04896.1	33.5	215	221	541	1.65e-22	94.0
k141_76562_2	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	33.5	215	221	541	1.65e-22	94.0
k141_76562_2	NCBI|WP_114500971.1|1|1|mcr-3.39|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.39|AMR|peptide	33.5	215	221	541	1.65e-22	94.0
k141_76562_2	SARG|gb|AST36143.1|ARO:3004509|MCR-3.8	33.5	215	221	540	3.05e-22	93.2
k141_76562_2	NCBI|WP_094313523.1|1|1|mcr-3.23|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.23|AMR|peptide	33.0	215	221	541	3.05e-22	93.2
k141_434152_3	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	369	351	655	7.12e-47	167
k141_434152_3	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	369	351	655	1.87e-46	166
k141_434152_3	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	2.58e-46	166
k141_434152_3	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	2.58e-46	166
k141_434152_3	SARG|gb|AKA86814|ARO:3003746|optrA	31.7	369	351	655	2.58e-46	166
k141_434152_3	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	4.90e-46	165
k141_434152_3	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	6.76e-46	164
k141_434152_3	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	6.76e-46	164
k141_434152_3	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	6.76e-46	164
k141_434152_3	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.7	369	351	655	6.76e-46	164
k141_66700_5	CARD|gb|AAC75429.1|ARO:3000833|evgS	25.9	255	881	1197	6.45e-16	81.6
k141_66700_5	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.9	123	881	219	1.85e-09	57.8
k141_66700_5	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.9	123	881	219	1.85e-09	57.8
k141_66700_5	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.9	123	881	220	1.88e-09	57.8
k141_66700_5	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	28.6	119	881	220	2.53e-09	57.4
k141_66700_5	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.1	123	881	220	1.13e-08	55.5
k141_262642_4	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	35.9	167	168	255	6.18e-28	103
k141_262642_4	SARG|gi|516510995|ref|WP_017899433.1|	37.8	164	168	646	3.56e-27	105
k141_262642_4	SARG|gi|1031822889|ref|WP_064150402.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|490306253|ref|WP_004201358.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|950164608|ref|WP_057214157.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|895903124|ref|WP_049003730.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|694113305|ref|WP_032455256.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|764951644|ref|WP_044521907.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|1016069923|ref|WP_062914571.1|	37.8	164	168	646	4.86e-27	105
k141_262642_4	SARG|gi|896073592|ref|WP_049116987.1|	37.8	164	168	646	4.86e-27	105
k141_459303_2	SARG|gi|553755604|ref|WP_023088332.1|	26.7	464	470	472	8.31e-43	156
k141_459303_2	SARG|gi|757699586|ref|WP_042929352.1|	26.7	464	470	472	4.19e-42	154
k141_459303_2	SARG|YP_001348103	26.2	461	470	472	5.79e-42	154
k141_459303_2	SARG|gi|553784490|ref|WP_023115951.1|	26.7	464	470	472	5.79e-42	154
k141_459303_2	SARG|gi|763183668|ref|WP_044062270.1|	26.5	464	470	472	1.11e-41	153
k141_459303_2	SARG|gi|685983084|ref|WP_031690280.1|	26.5	464	470	472	1.53e-41	153
k141_459303_2	SARG|gi|686099038|ref|WP_031755887.1|	26.5	464	470	472	1.53e-41	153
k141_459303_2	SARG|gi|730611402|ref|WP_034052379.1|	26.2	461	470	472	1.53e-41	153
k141_459303_2	SARG|gi|553765230|ref|WP_023097551.1|	26.5	464	470	472	1.53e-41	153
k141_459303_2	SARG|YP_790742	26.5	464	470	472	2.11e-41	152
k141_459303_3	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	37.5	475	522	1074	5.61e-95	310
k141_459303_3	SARG|gi|966396486|ref|WP_058441292.1|	34.0	509	522	1063	5.69e-86	285
k141_459303_3	SARG|gi|966511896|ref|WP_058528450.1|	34.9	476	522	1061	1.47e-85	284
k141_459303_3	SARG|gi|966461601|ref|WP_058493954.1|	33.7	486	522	1054	1.31e-84	281
k141_459303_3	SARG|YP_348488	36.4	486	522	1043	4.24e-84	280
k141_459303_3	SARG|gi|966476691|ref|WP_058507424.1|	34.4	509	522	1063	7.32e-84	280
k141_459303_3	SARG|gi|654923461|ref|WP_028373991.1|	34.9	476	522	1069	2.06e-83	278
k141_459303_3	SARG|YP_001668663	36.3	479	522	1043	1.08e-82	276
k141_459303_3	SARG|gi|852273548|ref|WP_048328542.1|	36.5	482	522	1043	1.08e-82	276
k141_459303_3	SARG|gi|966506160|ref|WP_058522806.1|	34.5	476	522	1066	2.63e-82	275
k141_367346_2	SARG|gb|APB03219.1|ARO:3003986|TaeA	37.9	530	560	648	2.07e-116	358
k141_367346_2	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	7.44e-73	244
k141_367346_2	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.0	537	560	655	2.01e-72	243
k141_367346_2	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	2.81e-72	242
k141_367346_2	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	2.81e-72	242
k141_367346_2	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	2.81e-72	242
k141_367346_2	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	2.81e-72	242
k141_367346_2	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	2.81e-72	242
k141_367346_2	SARG|gb|AKA86814|ARO:3003746|optrA	30.4	539	560	655	2.81e-72	242
k141_367346_2	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	539	560	655	3.91e-72	242
k141_367346_5	SARG|gi|542061059|gb|ERI11611.1|	35.9	92	89	316	5.07e-11	55.8
k141_367346_5	SARG|gi|507035724|ref|WP_016107411.1|	36.1	72	89	309	3.33e-10	53.5
k141_367346_5	SARG|gi|445996729|ref|WP_000074584.1|	34.7	72	89	309	3.33e-10	53.5
k141_367346_5	SARG|gi|445996698|ref|WP_000074553.1|	36.1	72	89	309	3.33e-10	53.5
k141_367346_5	SARG|gi|445996695|ref|WP_000074550.1|	36.1	72	89	309	4.56e-10	53.1
k141_367346_5	SARG|gi|445996697|ref|WP_000074552.1|	36.1	72	89	309	4.56e-10	53.1
k141_367346_5	SARG|gi|445996723|ref|WP_000074578.1|	36.1	72	89	309	4.56e-10	53.1
k141_367346_5	SARG|gi|445996696|ref|WP_000074551.1|	36.1	72	89	309	4.56e-10	53.1
k141_367346_5	SARG|gi|445996722|ref|WP_000074577.1|	36.1	72	89	309	6.26e-10	52.8
k141_367346_5	SARG|gi|445996719|ref|WP_000074574.1|	36.1	72	89	309	8.58e-10	52.4
k141_147146_2	SARG|gb|ABX00624.1|ARO:3002881|lmrC	34.1	170	265	550	1.03e-20	90.1
k141_147146_2	ResF|poxtA-Ef_1_WP094899500.1_1	35.9	92	265	538	2.94e-16	77.0
k141_147146_2	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	35.9	92	265	543	2.95e-16	77.0
k141_147146_2	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	35.9	92	265	543	2.95e-16	77.0
k141_147146_2	NCBI|WP_000052512.1|1|1|msr(E)|msr(E)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(E)|AMR|multidrug	29.2	171	265	491	6.83e-16	75.9
k141_147146_2	SARG|gb|AVI44920.1|ARO:3004470|poxtA	24.4	213	265	542	1.07e-14	72.4
k141_147146_2	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	24.4	213	265	544	1.07e-14	72.4
k141_459540_1	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	46.1	447	494	1186	1.87e-117	371
k141_459540_1	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	46.1	447	494	1186	1.87e-117	371
k141_459540_1	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	45.8	448	494	1162	1.37e-114	363
k141_356549_3	SARG|gb|AAC74000.1|ARO:3003950|msbA	35.0	575	590	582	4.47e-109	338
k141_356549_3	SARG|gi|921231571|ref|WP_053176464.1|	30.2	583	590	620	1.83e-84	275
k141_356549_3	SARG|gi|917172177|ref|WP_051778889.1|	30.2	583	590	620	2.56e-84	274
k141_356549_3	SARG|gi|1045390184|ref|WP_065479071.1|	29.8	583	590	605	6.89e-84	273
k141_356549_3	SARG|gb|AYV52072.1|ARO:3002882|lmrD	34.9	496	590	664	1.36e-83	273
k141_356549_3	SARG|gi|919568551|ref|WP_052871170.1|	29.7	580	590	620	3.76e-83	271
k141_356549_3	SARG|gi|664042835|ref|WP_030582300.1|	30.8	578	590	604	7.09e-83	270
k141_356549_3	SARG|gi|917166849|ref|WP_051773561.1|	30.1	581	590	620	1.03e-82	270
k141_356549_3	SARG|gi|662129758|ref|WP_030081404.1|	30.4	583	590	605	1.42e-82	269
k141_356549_3	SARG|gi|917155568|ref|WP_051762280.1|	30.1	581	590	620	1.44e-82	270
k141_217253_2	megares|MEG_8662|Drugs|Metronidazole|rdxA_nitroimidazole_reductase|RDXA_1	28.9	76	177	210	6.38e-07	46.6
